The largest strategic meeting on medical cannabis and hemp in Brazil takes place in São Paulo, bringing together researchers, entrepreneurs, and professionals who are shaping the country's green future

Studies point to the substance's effectiveness in reducing anxious symptoms, but experts advocate caution and more clinical research

Experts report on how the meeting strengthens clinical practice, expands research, and opens up space for new businesses in the cannabis sector

Botswana has published new rules for cannabis, with THC limits, strict licenses, and control over cultivation, transportation, research, and export

Agency presents new report with no defined timeline, while experts warn that moving to Schedule III would have profound impacts on research and taxation, but not federal legalization

The DEA has increased the legal quotas for the production of psychedelics such as psilocybin and DMT for 2026, focusing on scientific and medical research in the United States

Expectation is that the president will issue an executive order transferring the plant to Schedule III; measure would facilitate research and banking access after cannabis reclassification

In Deusa Cast #46, experts like Jaime Ozi analyze the obstacles preventing Brazil from advancing in cannabis regulation and highlight the impact of lack of research, medical education, and access

Agronomist engineer Ana Paula Porfírio, head of the Social Participation and Diversity Advisory of the Ministry of Agriculture and Livestock (MAPA), and researcher Beatriz Emydio, from Embrapa, will participate in the panel “Cannabis in Brazil: Challenges and Perspectives of Post-Regulation Cultivation”

“Now is the time to devise strategies and discuss how to implement and improve the requirements that will come,” says Beatriz Marti Emygdio, researcher at Embrapa and president of the Permanent Committee on Cannabis (CPCAN)

Nearly 80% of middle-aged women turn to cannabis or CBD to relieve menopausal symptoms like sleep and mood, reveals Menopause research

Discover what cannabis ruderalis is, its main characteristics, uses, effects, and why it sparks the interest of growers and researchers

Parliamentarians, doctors, and associations advocated for greater access to treatments, evaluated the therapeutic potential of THC, and announced a R$ 1.25 million call for research and innovation in the sector.

The event brings together experts, companies, and authorities to discuss regulatory advances, research, and innovation in cannabis-based therapies, connecting the entire public and private sector

With applications ranging from the pharmaceutical industry to construction, the sector is being structured with machinery, research, and investments, and is expected to grow even before the definitive regulation of cultivation in Brazil; the consultant discussed the topic during an interview at Andav 2025

Agreement between regulatory agency and veterinary institute evaluates the use of cannabidiol as an alternative to antibiotics in poultry farming

Study shows that cannabis extract can reduce chronic lower back pain and improve patients' quality of life

Brazilian study proposes a new model on the C15:0 lipid, highlighting its triphasic action in regulating inflammation, metabolism, and longevity

Study shows that the combination of cannabis and propolis extracts can enhance antibacterial and anti-inflammatory effects, pointing to new possibilities for natural therapies

Brazilian study reveals the role of acid cannabinoids as markers of freshness, quality, and authenticity of cannabis, proposing a review of forensic protocols used in the country